Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

NCT02959658 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT02959658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02959658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2016
Completion date
December 9, 2020
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive multiple sclerosis